As of 2024-12-14, the Relative Valuation of Emergent BioSolutions Inc (EBS) is (60.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.48 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is -816.9%.
The range of the Relative Valuation is (58.58) - (60.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 15.6x | 15.2x |
| Forward P/E multiples | 15.2x - 17.5x | 16.4x |
| Fair Price | (58.58) - (60.12) | (60.79) |
| Upside | -790.8% - -809.0% | -816.9% |
| Date | P/E |
| 2024-12-12 | -2.25 |
| 2024-12-11 | -2.22 |
| 2024-12-10 | -2.23 |
| 2024-12-09 | -2.27 |
| 2024-12-06 | -2.34 |
| 2024-12-05 | -2.37 |
| 2024-12-04 | -2.45 |
| 2024-12-03 | -2.41 |
| 2024-12-02 | -2.55 |
| 2024-11-29 | -2.63 |
| 2024-11-27 | -2.62 |
| 2024-11-26 | -2.60 |
| 2024-11-25 | -2.56 |
| 2024-11-22 | -2.46 |
| 2024-11-21 | -2.44 |
| 2024-11-20 | -2.30 |
| 2024-11-19 | -2.15 |
| 2024-11-18 | -2.23 |
| 2024-11-15 | -2.00 |
| 2024-11-14 | -2.41 |
| 2024-11-13 | -2.59 |
| 2024-11-12 | -2.83 |
| 2024-11-11 | -3.11 |
| 2024-11-08 | -3.05 |
| 2024-11-07 | -2.85 |
| 2024-11-06 | -2.39 |
| 2024-11-05 | -2.32 |
| 2024-11-04 | -2.28 |
| 2024-11-01 | -2.37 |
| 2024-10-31 | -2.35 |
| 2024-10-30 | -2.49 |
| 2024-10-29 | -2.42 |
| 2024-10-28 | -2.51 |
| 2024-10-25 | -2.32 |
| 2024-10-24 | -2.35 |
| 2024-10-23 | -2.27 |
| 2024-10-22 | -2.40 |
| 2024-10-21 | -2.64 |
| 2024-10-18 | -2.43 |
| 2024-10-17 | -2.37 |
| 2024-10-16 | -2.38 |
| 2024-10-15 | -2.38 |
| 2024-10-14 | -2.34 |
| 2024-10-11 | -2.27 |
| 2024-10-10 | -2.19 |
| 2024-10-09 | -2.32 |
| 2024-10-08 | -2.39 |
| 2024-10-07 | -2.39 |
| 2024-10-04 | -2.43 |
| 2024-10-03 | -2.32 |